THE EFFECTS OF NALTREXONE ON ACTIVE CROHN'S DISEASE

纳曲酮对活动性克罗恩病的影响

• 批准号: 7625800
• 负责人: Jill P Smith
• 金额: $ 1.67万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625800
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Crohn' s disease; Enkephalins; Funding; Grant; Inflammation; Institution; Intestines; Naltrexone; Oral; Research; Research Personnel; Resources; Source; United States National Institutes of Health; improved

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The hypothesis for this study is that oral naltrexone will improve inflammation of the bowel by increasing endogenous enkephalin levels in subjects with active Crohn's disease.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的假设是，口服纳曲酮将通过增加活性克罗恩病的受试者中内源性ankephalin水平来改善肠道的炎症。